Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Impact of a primary care based intervention on breast cancer knowledge, risk perception and concern: A randomized, controlled trial.

Livaudais-Toman J, Karliner LS, Tice JA, Kerlikowske K, Gregorich S, Pérez-Stable EJ, Pasick RJ, Chen A, Quinn J, Kaplan CP.

Breast. 2015 Dec;24(6):758-66. doi: 10.1016/j.breast.2015.09.009. Epub 2015 Oct 21.

2.

Quantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort of BRCA1/2 mutation carriers.

Wu S, Weinstein SP, DeLeo MJ 3rd, Conant EF, Chen J, Domchek SM, Kontos D.

Breast Cancer Res. 2015 May 19;17:67. doi: 10.1186/s13058-015-0577-0. Erratum in: Breast Cancer Res. 2015;17:144.

3.

Intranasal delivery of liposomal indole-3-carbinol improves its pulmonary bioavailability.

Song JM, Kirtane AR, Upadhyaya P, Qian X, Balbo S, Teferi F, Panyam J, Kassie F.

Int J Pharm. 2014 Dec 30;477(1-2):96-101. doi: 10.1016/j.ijpharm.2014.10.018. Epub 2014 Oct 11.

4.

Current strategies for the prevention of breast cancer.

Advani P, Moreno-Aspitia A.

Breast Cancer (Dove Med Press). 2014 May 2;6:59-71. doi: 10.2147/BCTT.S39114. eCollection 2014. Review.

5.

A randomized, controlled trial to increase discussion of breast cancer in primary care.

Kaplan CP, Livaudais-Toman J, Tice JA, Kerlikowske K, Gregorich SE, Pérez-Stable EJ, Pasick RJ, Chen A, Quinn J, Karliner LS.

Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1245-53. doi: 10.1158/1055-9965.EPI-13-1380. Epub 2014 Apr 24.

6.

CAGS and ACS evidence based reviews in surgery. 48. What is the effect of screening mammography on breast cancer incidence?

Latosinsky S, Boileau JF, Bryant HE, Newman LA; Evidence-Based Reviews in Surgery Group.

Can J Surg. 2014 Feb;57(1):67-9. No abstract available.

7.

Exercise lowers estrogen and progesterone levels in premenopausal women at high risk of breast cancer.

Kossman DA, Williams NI, Domchek SM, Kurzer MS, Stopfer JE, Schmitz KH.

J Appl Physiol (1985). 2011 Dec;111(6):1687-93. doi: 10.1152/japplphysiol.00319.2011. Epub 2011 Sep 8.

8.

Enhanced inhibition of lung adenocarcinoma by combinatorial treatment with indole-3-carbinol and silibinin in A/J mice.

Dagne A, Melkamu T, Schutten MM, Qian X, Upadhyaya P, Luo X, Kassie F.

Carcinogenesis. 2011 Apr;32(4):561-7. doi: 10.1093/carcin/bgr010. Epub 2011 Jan 27.

9.

Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information.

Mealiffe ME, Stokowski RP, Rhees BK, Prentice RL, Pettinger M, Hinds DA.

J Natl Cancer Inst. 2010 Nov 3;102(21):1618-27. doi: 10.1093/jnci/djq388. Epub 2010 Oct 18.

10.

Inhibition of lung carcinogenesis and critical cancer-related signaling pathways by N-acetyl-S-(N-2-phenethylthiocarbamoyl)-l-cysteine, indole-3-carbinol and myo-inositol, alone and in combination.

Kassie F, Melkamu T, Endalew A, Upadhyaya P, Luo X, Hecht SS.

Carcinogenesis. 2010 Sep;31(9):1634-41. doi: 10.1093/carcin/bgq139. Epub 2010 Jul 5.

11.

Australian clinicians and chemoprevention for women at high familial risk for breast cancer.

Keogh LA, Hopper JL, Rosenthal D, Phillips KA.

Hered Cancer Clin Pract. 2009 May 4;7(1):9. doi: 10.1186/1897-4287-7-9.

12.

Chemoprevention of lung cancer.

Keith RL.

Proc Am Thorac Soc. 2009 Apr 15;6(2):187-93. doi: 10.1513/pats.200807-067LC. Review.

13.

Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk.

Cummings SR, Tice JA, Bauer S, Browner WS, Cuzick J, Ziv E, Vogel V, Shepherd J, Vachon C, Smith-Bindman R, Kerlikowske K.

J Natl Cancer Inst. 2009 Mar 18;101(6):384-98. doi: 10.1093/jnci/djp018. Epub 2009 Mar 10. Review.

14.

Towards a more comprehensive understanding of cancer burden in North Carolina: priorities for intervention.

Carpenter WR, Beskow LM, Blocker DE, Forlenza MJ, Kim AE, Pevzner ES, Rose JM, Tran AN, Webber KH, Knight K, O'Malley MS.

N C Med J. 2008 Jul-Aug;69(4):275-82.

15.

Estrogen receptor genotypes, menopausal status, and the lipid effects of tamoxifen.

Ntukidem NI, Nguyen AT, Stearns V, Rehman M, Schott A, Skaar T, Jin Y, Blanche P, Li L, Lemler S, Hayden J, Krauss RM, Desta Z, Flockhart DA, Hayes DF; Consortium on Breast Cancer Pharmacogenomics.

Clin Pharmacol Ther. 2008 May;83(5):702-10. Epub 2007 Aug 22.

16.

Women's views on chemoprevention of breast cancer: qualitative study.

Heisey R, Pimlott N, Clemons M, Cummings S, Drummond N.

Can Fam Physician. 2006 May;52:624-5.

17.

Impact of the Cancer Risk Intake System on patient-clinician discussions of tamoxifen, genetic counseling, and colonoscopy.

Skinner CS, Rawl SM, Moser BK, Buchanan AH, Scott LL, Champion VL, Schildkraut JM, Parmigiani G, Clark S, Lobach DF, Bastian LA.

J Gen Intern Med. 2005 Apr;20(4):360-5.

18.

Meta-analysis of vascular and neoplastic events associated with tamoxifen.

Braithwaite RS, Chlebowski RT, Lau J, George S, Hess R, Col NF.

J Gen Intern Med. 2003 Nov;18(11):937-47.

Supplemental Content

Support Center